MARKET

ALPMF

ALPMF

Astellas Pharma
OTCPK
9.90
NaN%
Closed 09:30 03/14 EDT
OPEN
--
PREV CLOSE
9.90
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
55.93
52 WEEK LOW
9.50
MARKET CAP
17.72B
P/E (TTM)
-48.0349
1D
5D
1M
3M
1Y
5Y
1D
Astellas Pharma: Raising New, As Yet Unanswered Questions In Stomach Cancer And Moving Their Pipeline Forward
Seeking Alpha · 1d ago
Weekly Report: what happened at ALPMF last week (0303-0307)?
Weekly Report · 6d ago
J.P. Morgan Remains a Hold on Astellas Pharma (ALPMF)
TipRanks · 03/08 12:06
Astellas and YASKAWA form JV focused on cell therapy manufacturing
Seeking Alpha · 03/06 07:50
Weekly Report: what happened at ALPMF last week (0224-0228)?
Weekly Report · 03/03 11:12
Weekly Report: what happened at ALPMF last week (0217-0221)?
Weekly Report · 02/24 11:12
Medicare price talks defended by DoJ as Trump pledges to lower drug prices
Seeking Alpha · 02/21 19:18
Weekly Report: what happened at ALPMF last week (0210-0214)?
Weekly Report · 02/17 11:09
More
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMF stock methods without spending real money on the virtual paper trading platform.